Senzime Licensee Fukuda Denshi Launches Integrated TetraGraph Module in Japanese Market
UPPSALA, SE / ACCESSWIRE / February 7, 2024 / Senzime (STO:SEZI)(OTCQX:SNZZF) Senzime, an industry leader in algorithm-based patient monitoring solutions,...
Month: February 2024
InfinityRx Appoints Kevin Wong as Chief Technology Officer
Empowering Our Clients With Advanced SolutionsNEW HYDE PARK, NY / ACCESSWIRE / February 7, 2024 / InfinityRx, a copay program...
InfinityRx Appoints Kevin Wong as Chief Technology Officer
Empowering Our Clients With Advanced SolutionsNEW HYDE PARK, NY / ACCESSWIRE / February 7, 2024 / InfinityRx, a copay program...
Two Labs Launches Sunshine Transparency and Aggregate Spend Offering to Provide Transparency Reporting and Compliance Support to the Pharma Industry
COLUMBUS, OH / ACCESSWIRE / February 7, 2024 / Today, Two Labs, an Envision Pharma Company and industry leader in...
Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
SEATTLE, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single molecule...
Clearside Biomedical Announces Pricing of $15 Million Registered Direct Offering
ALPHARETTA, Ga., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (“Clearside” or the “Company”) (NASDAQ: CLSD), a biopharmaceutical company revolutionizing...
PetVivo Holdings, Inc. Announces Release of Clinical Study Results Involving Feline Tolerance to Intra-articular Injections of Spryng™ with OsteoCushion™ Technolgoy
MINNEAPOLIS, MN, US, Feb. 07, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) (the “Company” or “PetVivo")...
Disc Medicine Strengthens Leadership Team with Appointment of Seasoned Industry Executive Jean Franchi as Chief Financial Officer, and Promotion of Jonathan Yu to Chief Operating Officer
Jean Franchi is an industry veteran and brings over 30 years of leadership experience in finance, investor relations, capital formation,...
Stryker declares a $0.80 per share quarterly dividend
Portage, Michigan, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly...
Pacira BioSciences Awarded Brand Pharmaceuticals Agreement With Premier, Inc.
TAMPA, Fla., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc., (Nasdaq: PCRX), the industry leader in its commitment to...
Avadel Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
DUBLIN, Ireland, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines...
Rhythm Pharmaceuticals Announces Positive Reimbursement Decision in Italy for IMCIVREE® (setmelanotide) for the Treatment of Obesity and Control of Hunger in Bardet-Biedl Syndrome
BOSTON, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming...
Theriva Biologics Announces Positive Recommendation from the Independent Data Monitoring Committee of VIRAGE, the Phase 2b Clinical Trial of VCN-01 in Combination with Chemotherapy for Metastatic Pancreatic Ductal Adenocarcinoma
The independent data monitoring committee (IDMC) recommended the continuation of VIRAGE with no safety concerns raised; VIRAGE remains on track...
Enlivex Announces Issuance of New U.S. Patent Covering Allocetra Cells and Their Manufacturing Method
Nes-Ziona, Israel, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd., (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy...
New Survey Highlights Dire State of Nursing in 2024, Finds Optimism from Nurses Still in Profession
IntelyCare's nationwide survey of nurses and nursing assistants points to workload, safety, care quality, and other concernsQUINCY, Mass., Feb. 07,...
One month left to submit a claim under the First Nations Drinking Water Settlement
TORONTO, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Eligible First Nations communities and individuals have until March 7, 2024, to submit...
Daxor Corporation Closes Q4 2023 with Growth in New Sales to Hospital Systems and Increased Utilization of its BVA-100® Blood Volume Diagnostic Across the U.S. at Existing Accounts
Daxor's ezBVA Lab Service Plays a Significant Role in Driving Growth and Fostering Widespread Adoption Oak Ridge, TN, Feb. 07,...
Skye Bioscience to Present at Oppenheimer Investor Conference
San Diego, California--(Newsfile Corp. - February 7, 2024) - Skye Bioscience, Inc. (OTCQB: SKYE) ("Skye"), a clinical-stage biotechnology company focused...
Groundbreaking Digital Health Platform Set to Transform Healthcare in the UK
LONDON, UK / ACCESSWIRE / February 7, 2024 / An innovative digital health platform is transforming how medical professionals manage...
V&P Scientific Partners With Bioz to Provide Researchers With Validated Product Insights
PALO ALTO, CA / ACCESSWIRE / February 7, 2024 / Bioz, Inc., a leading AI software company based in Silicon...